<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Stock Analysis: Johnson &amp; Johnson (JNJ) *</title>
	<atom:link href="http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/feed/" rel="self" type="application/rss+xml" />
	<link>http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/</link>
	<description>Dividend Investing &#38; Value Investing For A Superior Portfolio</description>
	<lastBuildDate>Mon, 11 Apr 2011 13:45:49 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
	<item>
		<title>By: Anonymous</title>
		<link>http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/comment-page-1/#comment-2671</link>
		<dc:creator>Anonymous</dc:creator>
		<pubDate>Thu, 23 Oct 2008 05:24:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/#comment-2671</guid>
		<description>Google &quot;CNN Johnson &amp; johnson&quot; and read the first article that comes up.&lt;br/&gt;&lt;br/&gt;Sean Dix&lt;br/&gt;www.FlossRings.com</description>
		<content:encoded><![CDATA[<p>Google &quot;CNN Johnson &amp; johnson&quot; and read the first article that comes up.</p>
<p>Sean Dix<br /><a href="http://www.FlossRings.com" rel="nofollow">http://www.FlossRings.com</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dividends4Life</title>
		<link>http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/comment-page-1/#comment-2432</link>
		<dc:creator>Dividends4Life</dc:creator>
		<pubDate>Sun, 22 Jun 2008 03:31:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/#comment-2432</guid>
		<description>Anon: It is all about the entry point.  I waited for years before I got an acceptable entry point for JNJ.  It has performed well for me.  I have been waiting for an good entry point for PG - it seems like forever. it is getting close.&lt;br/&gt;&lt;br/&gt;Best Wishes,&lt;br/&gt;D4L</description>
		<content:encoded><![CDATA[<p>Anon: It is all about the entry point.  I waited for years before I got an acceptable entry point for JNJ.  It has performed well for me.  I have been waiting for an good entry point for PG &#8211; it seems like forever. it is getting close.</p>
<p>Best Wishes,<br />D4L</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Anonymous</title>
		<link>http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/comment-page-1/#comment-2427</link>
		<dc:creator>Anonymous</dc:creator>
		<pubDate>Sat, 21 Jun 2008 14:32:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/#comment-2427</guid>
		<description>for the last 5 years my jnj stock has underperformed almost every other stock i&#039;ve held especially similar companies like P&amp;G.&lt;br/&gt;&lt;br/&gt;Last year I decided to investigate to form my own conclusions about why this is the case. &lt;br/&gt;&lt;br/&gt;The one, what I would call &quot;Major&quot; issue this company has is this. &lt;br/&gt;Upon review of the analyst presentations (Depuy, Ethicon and a few other MD&amp;D) I noticed a lot of replication in &quot;new products&quot; in the pipeline from the previous year. I chose these business because they are out of sight and of mind but represent a huge chunk of earnings&lt;br/&gt;&lt;br/&gt;My take away, was that the rumours there was nothing new to sustain the company, were in my opinion confirmed and I sold. &lt;br/&gt;&lt;br/&gt;I think they are a house of cards trying to catch up with previous mis-truths</description>
		<content:encoded><![CDATA[<p>for the last 5 years my jnj stock has underperformed almost every other stock i&#8217;ve held especially similar companies like P&#038;G.</p>
<p>Last year I decided to investigate to form my own conclusions about why this is the case. </p>
<p>The one, what I would call &#8220;Major&#8221; issue this company has is this. <br />Upon review of the analyst presentations (Depuy, Ethicon and a few other MD&#038;D) I noticed a lot of replication in &#8220;new products&#8221; in the pipeline from the previous year. I chose these business because they are out of sight and of mind but represent a huge chunk of earnings</p>
<p>My take away, was that the rumours there was nothing new to sustain the company, were in my opinion confirmed and I sold. </p>
<p>I think they are a house of cards trying to catch up with previous mis-truths</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jake (Dividend Investing Blog)</title>
		<link>http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/comment-page-1/#comment-2102</link>
		<dc:creator>Jake (Dividend Investing Blog)</dc:creator>
		<pubDate>Tue, 12 Feb 2008 12:51:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/#comment-2102</guid>
		<description>I have owned JNJ for a long time.  It has been a consistent performer.  A friend of mine likes to say JNJ is the closest thing to a health care mutual fund you can buy.</description>
		<content:encoded><![CDATA[<p>I have owned JNJ for a long time.  It has been a consistent performer.  A friend of mine likes to say JNJ is the closest thing to a health care mutual fund you can buy.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Thicken My Wallet</title>
		<link>http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/comment-page-1/#comment-2101</link>
		<dc:creator>Thicken My Wallet</dc:creator>
		<pubDate>Tue, 12 Feb 2008 05:20:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/#comment-2101</guid>
		<description>Good stock finally at a decent valuation. &lt;br/&gt;&lt;br/&gt;The pharma part of the company may take a hit if the Democrats win the White House and decide to control drug costs but its only short-term pain.</description>
		<content:encoded><![CDATA[<p>Good stock finally at a decent valuation. </p>
<p>The pharma part of the company may take a hit if the Democrats win the White House and decide to control drug costs but its only short-term pain.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dividends4Life</title>
		<link>http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/comment-page-1/#comment-2100</link>
		<dc:creator>Dividends4Life</dc:creator>
		<pubDate>Tue, 12 Feb 2008 02:15:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/#comment-2100</guid>
		<description>American Dividend Investor: I look forward to seeing your JNJ analysis.&lt;br/&gt;&lt;br/&gt;Dividend Growth: I have high hopes for JNJ.  It looks like I may get to buy more at a lower price.  Thanks for your kind words. By the time would get around to charging, it would be too late.  I will have given it all away in the free models.&lt;br/&gt;&lt;br/&gt;Best Wishes,&lt;br/&gt;D4L</description>
		<content:encoded><![CDATA[<p>American Dividend Investor: I look forward to seeing your JNJ analysis.</p>
<p>Dividend Growth: I have high hopes for JNJ.  It looks like I may get to buy more at a lower price.  Thanks for your kind words. By the time would get around to charging, it would be too late.  I will have given it all away in the free models.</p>
<p>Best Wishes,<br />D4L</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: dividend growth</title>
		<link>http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/comment-page-1/#comment-2099</link>
		<dc:creator>dividend growth</dc:creator>
		<pubDate>Mon, 11 Feb 2008 23:01:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/#comment-2099</guid>
		<description>I think that JNJ is the dividend investor&#039;s dream with its 14% annual average dividend growth for the past 10 years and its above average dividend yield. JNJ is a household name, and a Dow Jones contituent but most importantly a dividend aristocrat. I would also analyse JNJ next week to see what I would recommend.&lt;br/&gt;By the way your reports look very professional. Is your blog a bait and switch service, where you make your readers like your blog and then you start charging us for it? ;-)</description>
		<content:encoded><![CDATA[<p>I think that JNJ is the dividend investor&#8217;s dream with its 14% annual average dividend growth for the past 10 years and its above average dividend yield. JNJ is a household name, and a Dow Jones contituent but most importantly a dividend aristocrat. I would also analyse JNJ next week to see what I would recommend.<br />By the way your reports look very professional. Is your blog a bait and switch service, where you make your readers like your blog and then you start charging us for it? <img src='http://dividendsvalue.com/wp-includes/images/smilies/icon_wink.gif' alt=';-)' class='wp-smiley' /> </p>
]]></content:encoded>
	</item>
	<item>
		<title>By: American Dividend Investor</title>
		<link>http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/comment-page-1/#comment-2098</link>
		<dc:creator>American Dividend Investor</dc:creator>
		<pubDate>Mon, 11 Feb 2008 17:36:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1194/stock-analysis-johnson-johnson-jnj/#comment-2098</guid>
		<description>I&#039;ll be taking a look at JNJ this week as well, it will be interesting to see if our numbers are close.&lt;br/&gt;&lt;br/&gt;ADI,&lt;br/&gt;&lt;br/&gt;http://americandividendinvestor.blogspot.com</description>
		<content:encoded><![CDATA[<p>I&#8217;ll be taking a look at JNJ this week as well, it will be interesting to see if our numbers are close.</p>
<p>ADI,</p>
<p><a href="http://americandividendinvestor.blogspot.com" rel="nofollow">http://americandividendinvestor.blogspot.com</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>

